Titlebook: Malignant Pleural Mesothelioma; Advances in Pathogen Takashi Nakano,Takashi Kijima Book 2021 Springer Nature Singapore Pte Ltd. 2021 Asbest

只看該作者 · 發(fā)表于 2025-3-27 15:15:37

Frequent NF2 Inactivation in Mesothelioma: How Can We Treat Mesothelioma with Targeted Therapies forogenic cell cycle promoter genes such as . and growth factor/cytokine genes including . and .. Meanwhile, YAP1/TAZ may also act as a tumor suppressor under specific cellular contexts; for example, YAP1 promotes regulated cell death known as ferroptosis. These data indicate that the merlin (.)–Hippo

只看該作者 · 發(fā)表于 2025-3-27 20:21:47

Book 2021hes, such as immunotherapy based on immune checkpoint inhibitors, which has meanta paradigm shift in other types of cancer, and given some hope to MPM patients. In turn, it discusses recent molecular pathological studies on mesothelioma, which claim to offer more accurate classifications than tradit

只看該作者 · 發(fā)表于 2025-3-28 01:13:38

Takashi Nakano,Takashi KijimaProvides essential information on molecular genetics, epidemiology, translational research, and the latest results of clinical trials on mesothelioma.Consists of 5 themed sections: epidemiology, patho

只看該作者 · 發(fā)表于 2025-3-28 02:49:35

Respiratory Disease Series: Diagnostic Tools and Disease Managementshttp://image.papertrans.cn/m/image/621982.jpg

只看該作者 · 發(fā)表于 2025-3-28 08:21:58

978-981-15-9160-0Springer Nature Singapore Pte Ltd. 2021

只看該作者 · 發(fā)表于 2025-3-28 14:27:16

		自動登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-20 17:08
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved